These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine. Melkersson K; Hulting AL Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762 [No Abstract] [Full Text] [Related]
10. Some aspects of psychodynamic response to novel atypical antipsychotics. Murawiec S; Taflińska D; Tafliński T Harv Rev Psychiatry; 1999; 7(4):241-2. PubMed ID: 10579106 [No Abstract] [Full Text] [Related]
11. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis. Finkel B; Lerner A; Oyffe I; Rudinski D; Sigal M; Weizman A Int Clin Psychopharmacol; 1998 May; 13(3):133-5. PubMed ID: 9690981 [TBL] [Abstract][Full Text] [Related]
12. Case report: possible neuroleptic malignant syndrome associated with olanzapine. Moltz DA; Coeytaux RR J Clin Psychopharmacol; 1998 Dec; 18(6):485-6. PubMed ID: 9864084 [No Abstract] [Full Text] [Related]
20. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia. Levy E; Margolese HC; Chouinard G J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686 [No Abstract] [Full Text] [Related] [Next] [New Search]